Sympathomimetic amine combined with alpha-2A adrenergic agonist

This page covers all Sympathomimetic amine combined with alpha-2A adrenergic agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Dopamine transporter, norepinephrine transporter, alpha-2A adrenergic receptor.

Targets

Dopamine transporter, norepinephrine transporter, alpha-2A adrenergic receptor

Marketed (1)

• Adhansia XR · Purdue Pharma LP · Neurology / Psychiatry
  Adhansia XR is a combination of amphetamine salts and guanfacine that increases dopamine and norepinephrine activity while also activating alpha-2A adrenergic receptors to improve attention and reduce hyperactivity and impulsivity.

Patent intelligence

• sympathomimetic amine combined with alpha 2a adrenergic agonist patent landscape — aggregated cliff calendar, attackable patents, originator estates